KPIX CBS Evening News With Norah ODonnell November 30, 2021 23:35:00
And regeneron, makers of an antibody treatment that can reduce risk of hospitalization and death by 70% in high-risk patients, says early evidence shows it is less effective against omicron and may need to be updated. meanwhile, the u.s. is stepping up its surveillance system for tracking new coronavirus variants. >> we are now sequencing approximately 80,000 samples per week, about one in every seven p.c.r.-positive cases. and that's more than any other country. >> reporter: currently, testing antibody response against the new variant is dr. david ho of columbia university. >> we suspect that...
Source: archive.org